Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
14.99 USD | -4.40% | -10.28% | -15.88% |
05-09 | UBS Adjusts Price Target on REGENXBIO to $39 From $43, Maintains Buy Rating | MT |
05-08 | Transcript : REGENXBIO Inc., Q1 2024 Earnings Call, May 08, 2024 |
- Stock Market
- Equities
- RGNX Stock
- News REGENXBIO Inc.
- MarketScreener Strategies